MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/ede.0000000000000174

Медицинская библиотека · Epidemiology (Cambridge, Mass.) · 2014

Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations.

Häggström Christel, Stocks Tanja, Nagel Gabriele, Manjer Jonas, Bjørge Tone, Hallmans Göran, Engeland Anders, Ulmer Hanno, Lindkvist Björn, Selmer Randi, Concin Hans, Tretli Steinar, Jonsson Håkan, Stattin Pär

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Few previous studies of metabolic aberrations and prostate cancer risk have taken into account the fact that men with metabolic aberrations have an increased risk of death from causes other than prostate cancer. The aim of this study was to calculate, in a real-life scenario, the risk of prostate cancer diagnosis, prostate cancer death, and death from other causes.

METHODS

In the Metabolic Syndrome and Cancer Project, prospective data on body mass index, blood pressure, glucose, cholesterol, and triglycerides were collected from 285,040 men. Risks of prostate cancer diagnosis, prostate cancer death, and death from other causes were calculated by use of competing risk analysis for men with normal (bottom 84%) and high (top 16%) levels of each factor, and a composite score.

RESULTS

During a mean follow-up period of 12 years, 5,893 men were diagnosed with prostate cancer, 1,013 died of prostate cancer, and 26,328 died of other causes. After 1996, when prostate-specific antigen testing was introduced, men up to age 80 years with normal metabolic levels had 13% risk of prostate cancer, 2% risk of prostate cancer death, and 30% risk of death from other causes, whereas men with metabolic aberrations had corresponding risks of 11%, 2%, and 44%.

CONCLUSIONS

In contrast to recent studies using conventional survival analysis, in a real-world scenario taking risk of competing events into account, men with metabolic aberrations had lower risk of prostate cancer diagnosis, similar risk of prostate cancer death, and substantially higher risk of death from other causes compared with men who had normal metabolic levels.

Для цитирования: Häggström Christel, Stocks Tanja, Nagel Gabriele, Manjer Jonas, Bjørge Tone, Hallmans Göran, Engeland Anders, Ulmer Hanno, Lindkvist Björn, Selmer Randi, Concin Hans, Tretli Steinar, Jonsson Håkan, Stattin Pär. Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations.. Epidemiology (Cambridge, Mass.). 2014. DOI: 10.1097/ede.0000000000000174.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.